(Reuters) - Aerie Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration approved its eyedrop, Rhopressa, as a treatment for glaucoma, two months ahead of the expected date.
Glaucoma affects about 2.7 million people in the United States and is the second leading cause of blindness in the world.
Rhopressa helps lower the pressure due to a build up of fluid in the eye by targeting the trabecular meshwork, the main drain through which fluid flows out of the eye.
For more details: New breakthrough in ophthalmology
Macular degeneration is the leading cause of severe, irreversible vision loss. It occurs when the small central portion of the retina, known as the macula, deteriorates. Most common symptoms of this disease is increasing age. Macular degeneration treatment
ReplyDeleteDoze Pharmacy
ReplyDeleteCenforce 100mg Soldenafil 100mg Tablets
Buy Cenforce 100 mg Online,it contains Sildenafil Citrate. Male suffering from pulmonary arterial hypertension or erectile dysfunction can try Sildenfil Citrate. Sildenafil 100mg tablets On Best Prices USA today. Order for Sildenafil Citrate Tablet and treat ED.
Doze Pharmacy
Anti fungal
Anthelmintics & Anti-Worm
Isotroin 20mg Capsule (Isotretinoin)
Nublexa 40mg Tablet (Regorafenib)
Iverheal 3mg Tablet (Ivermectin)
Iverheal 6mg Tablet (Ivermectin)
Januvia 50mg Tablet (Sitagliptin)
Kamagra 100mg Oral Jelly (Sildenafil)
Vilitra 40mg Tablet (Vardenafil)
Mebex 100mg Tablet (Mebendazole)
Imatib 400mg Tablet (Imatinib)
Men's Health and so more please visit the web site
Doze Pharmacy